• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMC
Click for more information
0.00% 7.5¢

IMMURON LIMITED - Announcements

Market Cap $21.88M  ! watchlist Created with Sketch. Add to my watchlist

Immuron Limited is an Australia-based biopharmaceutical company focused on developing and... Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), IMM-529, and CampETEC.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
IMCAppendix 3Y - Change of Director's Interest Notice (EZ)20/05/13
IMCAppendix 3Y - Change of Director's Interest Notice (RA)20/05/13
IMCAppendix 3B & Section 708A Notice20/05/13
IMCResults of General Meeting - May 201317/05/13
IMCImmuron - Company Update May 201317/05/13
IMCBecoming a substantial holder14/05/13
IMCBecoming a substantial holder14/05/13
IMCBecoming a Substantial Shareholder (Capital Concerns P/L)08/05/13
IMCBecoming a substantial holder07/05/13
IMCAppendix 3Y - Change of Director's Interest Notice (DP)03/05/13
IMCAppendix 3Y - Change of Director's Interest Notice (EZ)03/05/13
IMCAppendix 3Y - Change of Director's Interest Notice (SW)03/05/13
IMCAppendix 3B & Updated Top 20 Shareholder Reports03/05/13
IMCIMC Announces Rights Issue Closure, Acceptance and Shortfall30/04/13
IMCCompany Secretary Appointment/Retirement19/04/13
IMCNotice of General Meeting and Explanatory Memorandum16/04/13
IMCProspectus for Rights Issue dispatched to Shareholders12/04/13
IMCLetter to Shareholders re Renounceable Rights Issue28/03/13
IMCRenounceable Issue- Entitlement and Acceptance form27/03/13
IMCProspectus -Underwritten Renounceable Rights IssuePRICE SENSITIVE27/03/13
IMCAppendix 3B- Fully UnderwrittenRenounceable Rights Issue27/03/13
IMCFully Underwritten Renounceable Rights IssuePRICE SENSITIVE27/03/13
IMCFinal Director's Interest Notice - J Baini26/03/13
IMCTrading HaltPRICE SENSITIVE25/03/13
IMCFurther Positive Results on Clostridium Difficile ProgramPRICE SENSITIVE04/03/13
IMCHalf Year Results and Accounts 31 December 2012PRICE SENSITIVE28/02/13
IMCResignation of Joe Baini as Director and CEO.PRICE SENSITIVE22/02/13
IMCDrawdown on Funding Facility with Paladin Labs Inc.18/02/13
IMCAppendix 3B06/02/13
IMCCLOSTRIDIUM DIFFICILE Project UpdatePRICE SENSITIVE17/12/12
IMCAGM Meeting Results26/11/12
IMCChairman's Address and CEO Presentation to AGM26/11/12
IMCAppendix 3B Issue of ESOP unlisted Options15/11/12
IMCPatersons Research Report13/11/12
IMCChairman's letter and Notice of Annual General Meeting25/10/12
IMCImmuron Company Update18/10/12
IMCInitial Director's Interest Notice15/10/12
IMCChange of Registered Office ands Business Address15/10/12
IMCDirector Appointment/Resignation11/10/12
IMCFinal Director's Interest Notice - Colin Chapman08/10/12
IMCBoard Changes - Roger Aston appointed Chairman08/10/12
IMCFull Year Statutory Accounts28/09/12
IMCPositive Results from Colostridium Difficile ProgramPRICE SENSITIVE19/09/12
IMCTravelan Distribution Agreement for China and TaiwanPRICE SENSITIVE12/09/12
IMCExpiry of Options and Issue of ESOP options04/09/12
IMCPreliminary Final Report for year ended 30 June 201231/08/12
IMCResults for Announcement to the MarketPRICE SENSITIVE31/08/12
IMCInfluenza program for Swine FluPRICE SENSITIVE15/08/12
IMCNIH Grant for Immuron's IMM 124E for Alcholic Fatty LiverPRICE SENSITIVE06/08/12
IMCChange of Director's Interest Notice - J Baini02/08/12
IMCChange of Director's Interest Notice x 5 - issue of options30/07/12
IMCAppendix 3B - Issue of options26/07/12
IMCChange of Director's Interest Notice- J Baini16/07/12
IMCAppendix 3B - Bonus issue of Options09/07/12
IMCProspectus for Bonus Issue of OptionsPRICE SENSITIVE09/07/12
IMCChange of Director's Interest - Joe Baini09/07/12
IMCExpiry of Unlisted June 2012 Options02/07/12
IMCAppendix 3B29/06/12
IMCTop 20 shareholders21/06/12
IMCChange of Director's Interests (4)19/06/12
IMCAppendix 3B- Share Purchase Plan Allotment19/06/12
IMCChange in Directors Shareholding - R Aston18/06/12
IMCFinalisation of Share Purchase PlanPRICE SENSITIVE18/06/12
IMCAllotment of Tranche 2 - 708A Cleansing Notice08/06/12
IMCExpiry of Unlisted 31 May 2012 Options06/06/12
IMCTravelan application - CanadaPRICE SENSITIVE04/06/12
IMCInitial Director's Interest Notices - J Baini and R Aston31/05/12
IMCResults of EGM (31 May)31/05/12
IMCChairman's Address and Presentation to EGM (31 May)31/05/12
IMCAppointment of Additional Directors25/05/12
IMCChange in substantial holding - Drill Investments Pty Ltd24/05/12
IMCExtension of SPP closing date18/05/12
IMCCEO Letter to Shareholders17/05/12
IMCPaladin submits Travelan for Regulatory Approval in Canada16/05/12
IMCChange in substantial holding - Drill Investments Pty Ltd14/05/12
IMCTravelan Distribution in Singapore, Malaysia and BruneiPRICE SENSITIVE14/05/12
IMCIMC Investor Presentation May 201210/05/12
IMCTravelan licensed to Thailand, Hong Kong, Cambodia, VietnamPRICE SENSITIVE10/05/12
IMCAgreement with Synlait Milk for Hyperimmune requirementsPRICE SENSITIVE07/05/12
IMCBecoming a substantial holder - Capital Concerns Pty Limited03/05/12
IMCBonus Issue of New Options03/05/12
IMCNotice of General Meeting and Proxy Form30/04/12
IMCShare Purchase Plan Offer Document and Cleansing Notice27/04/12
IMCCleansing Statement - Tranche 1 Placement27/04/12
IMCCleansing Statement Share Purchase Plan24/04/12
IMCAppendix 3B23/04/12
IMCCapital Raising announcementPRICE SENSITIVE23/04/12
IMCReinstatement to Official QuotationPRICE SENSITIVE23/04/12
IMCSuspension from Official QuotationPRICE SENSITIVE20/04/12
IMCTrading Halt RequestPRICE SENSITIVE18/04/12
IMCTrading HaltPRICE SENSITIVE18/04/12
IMCImmuron appoints Joe Baini Chief Executive OfficerPRICE SENSITIVE05/03/12
IMCHalf Yearly Report and AccountsPRICE SENSITIVE28/02/12
IMCShareholder Update - February 201223/02/12
IMCChange of Director's Interest Notices15/02/12
IMCInitial and Final Directors Interest Notices09/02/12
IMCClarification ot terms of Debenture with Paladin Labs Inc.09/02/12
IMCAppointment of Dr Stewart Washer as Non-Executive Director08/02/12
IMCImmuron Announces Board Changes08/02/12
IMCExpiry of Unlisted 31 January 2012 Options03/02/12
IMCAppendix 3Y - Change of Director's Interest Notice (EZ)
20/05/13
IMCAppendix 3Y - Change of Director's Interest Notice (RA)
20/05/13
IMCAppendix 3B & Section 708A Notice
20/05/13
IMCResults of General Meeting - May 2013
17/05/13
IMCImmuron - Company Update May 2013
17/05/13
IMCBecoming a substantial holder
14/05/13
IMCBecoming a substantial holder
14/05/13
IMCBecoming a Substantial Shareholder (Capital Concerns P/L)
08/05/13
IMCBecoming a substantial holder
07/05/13
IMCAppendix 3Y - Change of Director's Interest Notice (DP)
03/05/13
IMCAppendix 3Y - Change of Director's Interest Notice (EZ)
03/05/13
IMCAppendix 3Y - Change of Director's Interest Notice (SW)
03/05/13
IMCAppendix 3B & Updated Top 20 Shareholder Reports
03/05/13
IMCIMC Announces Rights Issue Closure, Acceptance and Shortfall
30/04/13
IMCCompany Secretary Appointment/Retirement
19/04/13
IMCNotice of General Meeting and Explanatory Memorandum
16/04/13
IMCProspectus for Rights Issue dispatched to Shareholders
12/04/13
IMCLetter to Shareholders re Renounceable Rights Issue
28/03/13
IMCRenounceable Issue- Entitlement and Acceptance form
27/03/13
IMCProspectus -Underwritten Renounceable Rights Issue
27/03/13PRICE SENSITIVE
IMCAppendix 3B- Fully UnderwrittenRenounceable Rights Issue
27/03/13
IMCFully Underwritten Renounceable Rights Issue
27/03/13PRICE SENSITIVE
IMCFinal Director's Interest Notice - J Baini
26/03/13
IMCTrading Halt
25/03/13PRICE SENSITIVE
IMCFurther Positive Results on Clostridium Difficile Program
04/03/13PRICE SENSITIVE
IMCHalf Year Results and Accounts 31 December 2012
28/02/13PRICE SENSITIVE
IMCResignation of Joe Baini as Director and CEO.
22/02/13PRICE SENSITIVE
IMCDrawdown on Funding Facility with Paladin Labs Inc.
18/02/13
IMCAppendix 3B
06/02/13
IMCCLOSTRIDIUM DIFFICILE Project Update
17/12/12PRICE SENSITIVE
IMCAGM Meeting Results
26/11/12
IMCChairman's Address and CEO Presentation to AGM
26/11/12
IMCAppendix 3B Issue of ESOP unlisted Options
15/11/12
IMCPatersons Research Report
13/11/12
IMCChairman's letter and Notice of Annual General Meeting
25/10/12
IMCImmuron Company Update
18/10/12
IMCInitial Director's Interest Notice
15/10/12
IMCChange of Registered Office ands Business Address
15/10/12
IMCDirector Appointment/Resignation
11/10/12
IMCFinal Director's Interest Notice - Colin Chapman
08/10/12
IMCBoard Changes - Roger Aston appointed Chairman
08/10/12
IMCFull Year Statutory Accounts
28/09/12
IMCPositive Results from Colostridium Difficile Program
19/09/12PRICE SENSITIVE
IMCTravelan Distribution Agreement for China and Taiwan
12/09/12PRICE SENSITIVE
IMCExpiry of Options and Issue of ESOP options
04/09/12
IMCPreliminary Final Report for year ended 30 June 2012
31/08/12
IMCResults for Announcement to the Market
31/08/12PRICE SENSITIVE
IMCInfluenza program for Swine Flu
15/08/12PRICE SENSITIVE
IMCNIH Grant for Immuron's IMM 124E for Alcholic Fatty Liver
06/08/12PRICE SENSITIVE
IMCChange of Director's Interest Notice - J Baini
02/08/12
IMCChange of Director's Interest Notice x 5 - issue of options
30/07/12
IMCAppendix 3B - Issue of options
26/07/12
IMCChange of Director's Interest Notice- J Baini
16/07/12
IMCAppendix 3B - Bonus issue of Options
09/07/12
IMCProspectus for Bonus Issue of Options
09/07/12PRICE SENSITIVE
IMCChange of Director's Interest - Joe Baini
09/07/12
IMCExpiry of Unlisted June 2012 Options
02/07/12
IMCAppendix 3B
29/06/12
IMCTop 20 shareholders
21/06/12
IMCChange of Director's Interests (4)
19/06/12
IMCAppendix 3B- Share Purchase Plan Allotment
19/06/12
IMCChange in Directors Shareholding - R Aston
18/06/12
IMCFinalisation of Share Purchase Plan
18/06/12PRICE SENSITIVE
IMCAllotment of Tranche 2 - 708A Cleansing Notice
08/06/12
IMCExpiry of Unlisted 31 May 2012 Options
06/06/12
IMCTravelan application - Canada
04/06/12PRICE SENSITIVE
IMCInitial Director's Interest Notices - J Baini and R Aston
31/05/12
IMCResults of EGM (31 May)
31/05/12
IMCChairman's Address and Presentation to EGM (31 May)
31/05/12
IMCAppointment of Additional Directors
25/05/12
IMCChange in substantial holding - Drill Investments Pty Ltd
24/05/12
IMCExtension of SPP closing date
18/05/12
IMCCEO Letter to Shareholders
17/05/12
IMCPaladin submits Travelan for Regulatory Approval in Canada
16/05/12
IMCChange in substantial holding - Drill Investments Pty Ltd
14/05/12
IMCTravelan Distribution in Singapore, Malaysia and Brunei
14/05/12PRICE SENSITIVE
IMCIMC Investor Presentation May 2012
10/05/12
IMCTravelan licensed to Thailand, Hong Kong, Cambodia, Vietnam
10/05/12PRICE SENSITIVE
IMCAgreement with Synlait Milk for Hyperimmune requirements
07/05/12PRICE SENSITIVE
IMCBecoming a substantial holder - Capital Concerns Pty Limited
03/05/12
IMCBonus Issue of New Options
03/05/12
IMCNotice of General Meeting and Proxy Form
30/04/12
IMCShare Purchase Plan Offer Document and Cleansing Notice
27/04/12
IMCCleansing Statement - Tranche 1 Placement
27/04/12
IMCCleansing Statement Share Purchase Plan
24/04/12
IMCAppendix 3B
23/04/12
IMCCapital Raising announcement
23/04/12PRICE SENSITIVE
IMCReinstatement to Official Quotation
23/04/12PRICE SENSITIVE
IMCSuspension from Official Quotation
20/04/12PRICE SENSITIVE
IMCTrading Halt Request
18/04/12PRICE SENSITIVE
IMCTrading Halt
18/04/12PRICE SENSITIVE
IMCImmuron appoints Joe Baini Chief Executive Officer
05/03/12PRICE SENSITIVE
IMCHalf Yearly Report and Accounts
28/02/12PRICE SENSITIVE
IMCShareholder Update - February 2012
23/02/12
IMCChange of Director's Interest Notices
15/02/12
IMCInitial and Final Directors Interest Notices
09/02/12
IMCClarification ot terms of Debenture with Paladin Labs Inc.
09/02/12
IMCAppointment of Dr Stewart Washer as Non-Executive Director
08/02/12
IMCImmuron Announces Board Changes
08/02/12
IMCExpiry of Unlisted 31 January 2012 Options
03/02/12
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
7.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $21.88M
Open High Low Value Volume
7.6¢ 7.6¢ 7.5¢ $9.071K 120.6K

Buyers (Bids)

No. Vol. Price($)
1 57518 7.5¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 10000 1
View Market Depth
Last trade - 15.45pm 22/11/2024 (20 minute delay) ?
IMC (ASX) Chart

Top Stories

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

Welcome to the end of another week. Let's start with what HotCopper users have been watching and discussing.
Scientific conference spotlights PYC's work on blindness disease treatment PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
HotCopper Highlights: Your most watched stocks for Week 47, 2024 In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing, through Week 47. Let’s get into it. 
Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in the hands of two industry giants. But what does this mean for Australians @ greater access to cheaper medicines or the loss of small, commun...
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.